Round voting button logo

H.R.5160

Stem Cell Therapeutic and Research Reauthorization Act of 2025

Chamber Passed·7/21/26

Reauthorizes the Stem Cell Therapeutic and Research Act of 2005 through 2031.

The Stem Cell Therapeutic and Research Reauthorization Act of 2025 extends the Stem Cell Therapeutic and Research Act of 2005 through fiscal years 2027 to 2031. It also reauthorizes the C.W. Bill Young Cell Transplantation Program under the Public Health Service Act for the same period. The bill allocates funding for these programs, ensuring continued support for stem cell research and therapies.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Last
Passed the House · Jul 21
Current
The Senate
Next
Senate floor vote

Sponsors

DDDDDDDDDDD
11
11
RRRRRRRRRRR
Democratic CaucusRepublican Caucus

History

Jul 21

Senate

Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.

Jul 20

House

Mr. Guthrie moved to suspend the rules and pass the bill, as amended.

Jul 20

House

Considered under suspension of the rules. (consideration: CR H4642-4643)